Article citationsMore>>
Treede, R.D., Rief, W., Barke, A. Aziz, Q., Bennett, M.I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N.B., First, M.B., Giamberardino, M.A., Kaasa, S., Kosek, E., Lavand'Homme, P., Nicholas, M., Perrot, S., Scholz, J., Schug, S., Smith, B.H., Svensson, P., Vlaeyen, J.W. and Wang, S.J. (2015) A Classification of Chronic Pain for ICD-11. Pain, 156, 1003-1007.
https://doi.org/10.1097/j.pain.0000000000000160
has been cited by the following article:
-
TITLE:
Diagnosis and Treatment of Attention-Deficit Hyperactivity Disorder in Patients with Chronic Pain
AUTHORS:
Satoshi Kasahara, Yumiko Okamura, Ko Matsudaira, Hiroyuki Oka, Yoshie Suzuki, Yasuko Murakami, Toshiharu Tazawa, Hayato Shimazaki, Shin-ichi Niwa, Yoshitsugu Yamada
KEYWORDS:
Atomoxetine, Attention Deficit Hyperactivity Disorder, Chronic Pain, Methylphenidate, Wender Utah Rating Scale
JOURNAL NAME:
Open Journal of Psychiatry,
Vol.7 No.4,
August
17,
2017
ABSTRACT: Aims: To investigate rates of attention-deficit hyperactivity disorder (ADHD) in patients with chronic pain attending a pain clinic, the effects of a screening measure for ADHD in patients with chronic pain, and the effects of ADHD drugs on both pain and ADHD symptoms. Methods: We retrospectively surveyed 110 patients with chronic pain visiting the Anesthesiology and Pain Relief Center at the University of Tokyo in Japan, who had also consulted a psychiatrist, between April 2012 and July 2015. Results: Of the total of 110 patients with chronic pain, 35 (31.8%) were also diagnosed with ADHD, and the average Wender Utah Rating Scale (WURS) score among the ADHD patients was 39.0 ± 22.1 (n = 25). Only 36.0% of these patients exceeded the cutoff value, suggesting that 64.0% of the patients with ADHD were not identified by screening with the WURS. Twenty-six patients initiated treatment with ADHD medication, with dosage adjustment completed in 21. Of these 21 patients 20 (95.0%) had improved ADHD symptoms. Improved pain symptoms were observed in 14 patients (66.6%), with a reduction in the pain numerical rating scale of 64.7% ± 30.1%. Conclusions: This is the first study investigating the comorbidity of ADHD and chronic pain at pain clinics showing a high level of comorbidity and amelioration of pain and ADHD symptoms with treatment. Careful interpretation is required when the WURS is used to screen patients with chronic pain.
Related Articles:
-
Casimir Komenan
-
Noori Akhtar-Danesh
-
Mohamed S. El Naschie
-
Antonio Mirijello, Giovanni Addolorato, Raffaele Landolfi
-
Ananda Prasad Panta, Ram Prasad Ghimire, Dinesh Panthi, Shankar Raj Pant